RFWD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.673600E-01
Normal-vs-Stage2
6.457400E-01
Normal-vs-Stage3
5.315400E-01
Normal-vs-Stage4
1.940620E-01
Stage1-vs-Stage2
8.921000E-01
Stage1-vs-Stage3
3.966200E-01
Stage1-vs-Stage4
3.462600E-01
Stage2-vs-Stage3
1.829020E-01
Stage2-vs-Stage4
2.013400E-01
Stage3-vs-Stage4
1.253020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.147400E-01
Normal-vs-AfricanAmerican
1.813000E-01
Normal-vs-Asian
6.473500E-02
Caucasian-vs-AfricanAmerican
1.019760E-01
Caucasian-vs-Asian
1.026230E-01
AfricanAmerican-vs-Asian
8.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.351800E-02
Normal-vs-Female
8.035400E-01
Male-vs-Female
4.565000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.890400E-01
Normal-vs-Age(41-60Yrs)
6.785200E-01
Normal-vs-Age(61-80Yrs)
2.285000E-01
Normal-vs-Age(81-100Yrs)
4.138400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.222200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.012600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.870000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.328400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.712600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.757600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.185000E-01
Normal-vs-Daily Drinker
7.251200E-01
Normal-vs-Weekly Drinker
2.806600E-01
Normal-vs-Occasional Drinker
5.638200E-01
Normal-vs-Social Drinker
8.216200E-01
Non Drinker-vs-Daily Drinker
1.135200E-01
Non Drinker-vs-Weekly Drinker
9.830400E-01
Non Drinker-vs-Occasional Drinker
8.846400E-01
Non Drinker-vs-Social Drinker
5.872600E-01
Daily Drinker-vs-Weekly Drinker
1.296800E-01
Daily Drinker-vs-Occasional Drinker
1.024040E-01
Daily Drinker-vs-Social Drinker
3.097000E-01
Weekly Drinker-vs-Occasional Drinker
8.725800E-01
Weekly Drinker-vs-Social Drinker
5.614400E-01
Occasional Drinker-vs-Social Drinker
5.940400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.556970E-01
Normal-vs-Grade 2
9.638000E-03
Normal-vs-Grade 3
1.689690E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.086430E-01
Grade 1-vs-Grade 3
8.132300E-02
Grade 1-vs-Grade 4
1.556970E-01
Grade 2-vs-Grade 3
7.744600E-01
Grade 2-vs-Grade 4
9.638000E-03
Grade 3-vs-Grade 4
1.689690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.287400E-01
Normal-vs-NonDiabetic
1.045820E-01
Diabetic-vs-NonDiabetic
1.167570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.805600E-01
Normal-vs-NoPancreatitis
8.066000E-01
Pancreatitis-vs-NoPancreatitis
3.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.583900E-02
Normal-vs-N1
7.474600E-01
N0-vs-N1
1.950580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.658560E-01
Normal-vs-TP53-NonMutant
6.961000E-01
TP53-Mutant-vs-TP53-NonMutant
1.466360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
